The U.S. Pain Foundation recently submitted comments to the Food and Drug Administration (FDA) in response to its...

The U.S. Pain Foundation recently submitted comments to the Food and Drug Administration (FDA) in response to its...
Note: The following has been submitted to the CDC in response to the Revised Draft CDC Clinical Practice Guideline for...
Congressional Budget Reports accompany the annual federal budget that Congress develops each year. In these...
U.S. Pain Foundation’s Cindy Steinberg, National Director of Policy and Advocacy, has been leading a small workgroup...
In honor of Pain Awareness Month, the U.S. Pain Foundation and the Alliance to Advance Comprehensive Integrative Pain...
What better way to honor Pain Awareness Month than taking action at the federal level? Here are a few opportunities to...
On July 22, the Centers for Disease Control and Prevention (CDC) held a meeting of the Board of Scientific Counselors...
The U.S. Pain Foundation recently has been participating in the Collaborative for CBD Science & Safety (CCSS),...
Your advocacy has made an impact. Congress has directed the Department of Health and Human Services to disseminate the...
Last month, the U.S. Pain Foundation rallied a total of 761 pain warriors nationwide to urge Congress to allocate...
Approximately 5,400 individuals and organizations responded to the Centers for Disease Control and Prevention (CDC)’s...
U.S. Pain is pleased to share that Louisiana Governor John Bel Edwards has signed into law House Bill 819, which...